Company intelligence / Profile preview
Jiangsu Sinorda Biomedicine Co., Ltd.
Chinasinorda.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Jiangsu Sinorda Biomedicine is a Chinese biotech/pharma company focused on innovative drug development for gastrointestinal diseases and oncology immunotherapy. It has three clinical-stage candidates including a Class I new drug potassium competitive acid blocker X842 (NDA accepted), the SLN-T sentinel lymph node T-cell anti-tumor drug in Phase II trials in Europe, and the RIGVIR oncolytic virus drug with IND registration ongoing. The company has established international collaborations and strategic partnerships to accelerate its pipeline.
- Therapeutic areas
- GastroenterologyOncology
- Modalities
- Small moleculesBiological products (biologics)Virotherapy/oncolytic virusesTherapeutic vaccinesBispecific antibodies
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Cinclus Pharma AG – license agreement for linaprazan glurate development/commercialization in AsiaSPH Sine Pharmaceutical Laboratories – sub-licensee of linaprazan glurate manufacturing/sales rights in China/Hong Kong/Macau/TaiwanSanyou Biopharmaceuticals – bispecific antibody co-development partnershipPorton Advanced – strategic collaboration on cell therapy development for solid tumors via subsidiary Jiangsu Tairui Sinorda
Beyond the preview
Go deeper on Jiangsu Sinorda Biomedicine Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangsu Sinorda Biomedicine Co., Ltd..